Brief: Arctic Bioscience: Positive Order Backlog For 2024 For Nutraceutical Business

Arctic Bioscience AS

01/03/2024 07:03

March 1 (Reuters) - Arctic Bioscience AS  ABSA.OL :
    * POSITIVE ORDER BACKLOG FOR 2024 FOR NUTRACEUTICAL BUSINESS
    * WITH ALL NEEDED PATIENTS NOW RECRUITED INTO HEROPA
CLINICAL
TRIAL, WE EXPECT READ-OUT OF 6 MONTHS PRIMARY END POINTS IN H2
2024
    * AIMING FOR SOLID SALES GROWTH IN COMING YEARS AND FORECAST
BREAK-EVEN CONTRIBUTION FROM NUTRACEUTICAL BUSINESS BY END OF
2025

Source text for Eikon:  ID:nWkr1NWGqk 
Further company coverage:  ABSA.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))